Patents Represented by Attorney Charles J. Knuth
  • Patent number: 4624256
    Abstract: High molecular weight caprolactone polymers are coated on surgical sutures to improve suture properties such as smooth surface, single knot slipdown, two throw knot slipdown for repositioning, and three throw knot security.
    Type: Grant
    Filed: September 11, 1985
    Date of Patent: November 25, 1986
    Assignee: Pfizer Hospital Products Group, Inc.
    Inventors: Kenneth A. Messier, Joseph D. Rhum
  • Patent number: 4625041
    Abstract: A new acidic polycyclic ether antibiotic, CP-63,517, having the formula: ##STR1## and cationic salts thereof produced by submerged aerobic propagation of Streptomyces endus subsp. aureus, ATCC-39574, a new strain of microorganism isolated from a soil sample in Japan, a process for producing this antibiotic and methods for its use to improve feed utilization, promote growth of cattle and swine and to control coccidiosis.
    Type: Grant
    Filed: August 29, 1985
    Date of Patent: November 25, 1986
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Walter P. Cullen, Hiroshi Maeda, Junsuke Tone
  • Patent number: 4623650
    Abstract: 1-Substituted-6-fluoro-7-aryl-(8-fluoro)-1,4-dihydroquinol-4-one 3-carboxylic acids having antibacterial activity are prepared by reacting the corresponding alkyl 1-substituted-6-fluoro-7-bromo-(8-fluoro)-1,4-dihydroquinol-4-one-3-carbox ylate with an arylmetallic compound and hydrolyzing the ester formed.
    Type: Grant
    Filed: December 6, 1984
    Date of Patent: November 18, 1986
    Assignee: Pfizer Inc.
    Inventors: Paul J. Gilligan, Paul R. McGuirk, Michael J. Witty
  • Patent number: 4623486
    Abstract: Certain novel p-aminomethylbenzoyl derivatives of 4-hydroxy-2-methyl-N-(2-pyridinyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide and several other closely-related known oxicams have been prepared. These particular compounds are useful in therapy as prodrug forms of the known anti-inflammatory and analgesic oxicams. Preferred member compounds include 2-methyl-4-[4-(morpholinomethyl)benzoyloxy]-N-(2-pyridinyl)-2H-1,2-benzoth iazine-3-carboxamide 1,1-dioxide, 2-methyl-4-[4-(piperidinomethyl)benzoyloxy]-N-(2-pyridinyl)-2H-1,2-benzoth iazine-3-carboxamide 1,1-dioxide, 2-methyl-N-(6-methyl-2-pyridinyl)-4-[4-(piperidinomethyl)benzoyloxy]-2H-1, 2-benzothiazine-3-carboxamide 1,1-dioxide, 2-methyl-4-[4-(4-methylpiperazinomethyl)benzoyloxy]-N-(2-pyridinyl)-2H-1,2 -benzothiazine-3-carboxamide 1,1-dioxide and 2-methyl-4-[4-(pyridiniummethyl)benzoyloxy]-N-(2-pyridinyl)-2H-1,2-benzoth iazine-3-carboxamide 1,1-dioxide chloride. Methods for preparing these compounds from known starting materials are provided.
    Type: Grant
    Filed: May 29, 1985
    Date of Patent: November 18, 1986
    Assignee: Pfizer Inc.
    Inventor: Joseph G. Lombardino
  • Patent number: 4623725
    Abstract: A series of novel [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives wherein the amine group is optionally substituted with lower alkyl, phenylalkyl having up to three carbon atoms in the alkyl moiety or alkanoyl having from two to five carbon atoms, or the amine group alternatively completes a piperazino ring, the quinoxaline ring is optionally substituted with fluorine, chlorine, bromine or methoxy, and the triazolo ring is optionally substituted with lower alkyl, lower perfluoroalkyl or phenyl are disclosed. These novel compounds are useful for treatment of symptoms associated with depression. Also disclosed are pharmaceutical compositions containing the novel compounds of this invention.
    Type: Grant
    Filed: November 8, 1985
    Date of Patent: November 18, 1986
    Assignee: Pfizer Inc.
    Inventors: Saul B. Kadin, Reinhard Sarges
  • Patent number: 4623728
    Abstract: Certain novel 1-(substituted-alkyl)-3-(3-hydroxyphenyl)piperidine compounds, and the pharmeceutically-acceptable acid-addition salts thereof, possess pharmaceutical activity as neuroleptic agents, and they are useful for treating psychotic disorders, e.g. schizophrenia, in human subjects. In particular, they are useful for alleviating such symptoms as anxiety, agitation, excessive aggression, tension and social or emotional withdrawal in psychotic patients.Certain 3-(3-methoxyphenyl)piperidine compounds are useful as chemical intermediates to the aforementioned neuroleptic agents.
    Type: Grant
    Filed: February 14, 1986
    Date of Patent: November 18, 1986
    Assignee: Pfizer Inc.
    Inventor: Reinhard Sarges
  • Patent number: 4621630
    Abstract: A guide for femoral neck osteotomy comprises a longitudinal rod having attaching structure at the lower end thereof for securing the rod to a femur at the greater trochanter. A transversely extending support arm is secured to the rod adjacent the lower end thereof, and a guide bar is connected to the support arm. The guide bar has at least one elongate planar surface disposed at an angle of 45.degree. to the axis of the rod. In use, the rod is aligned with the long shaft axis of the femur and attached to the femur at the greater trochanter. The rod is manipulated until the support arm and the long shaft axis of the tibia are disposed in the same plane. This procedure properly positions the elongate planar surface of the guide bar whereby an instrument in engagement with that surface traverses the femoral neck at an angle of 45.degree. to the long shaft axis of the femur.
    Type: Grant
    Filed: April 15, 1983
    Date of Patent: November 11, 1986
    Assignee: Pfizer Hospital Products Group, Inc.
    Inventor: Robert V. Kenna
  • Patent number: 4622406
    Abstract: Hypoglycemic 5-furyl and 5-thienyl derivatives of oxazolidine-2,4-dione and the pharmaceutically-acceptable salts thereof; certain 3-acylated derivatives thereof; and intermediates useful in the preparation of said compounds.
    Type: Grant
    Filed: September 17, 1985
    Date of Patent: November 11, 1986
    Assignee: Pfizer Inc.
    Inventor: Rodney C. Schnur
  • Patent number: 4621638
    Abstract: A surgical suture made of a polymer filament having the "hard" elastic properties of reversible elasticity and retention of diameter on stretching.
    Type: Grant
    Filed: July 15, 1985
    Date of Patent: November 11, 1986
    Assignee: Pfizer Hospital Products Group, Inc.
    Inventor: Thomas A. Silvestrini
  • Patent number: 4622233
    Abstract: Methods for preparing purified, decolorized polydextrose having a lower caloric value, higher pH and less color than presently available commercial material, and the use of said improved product in edible foodstuffs and beverages.
    Type: Grant
    Filed: December 6, 1984
    Date of Patent: November 11, 1986
    Assignee: Pfizer Inc.
    Inventor: Anibal Torres
  • Patent number: 4620533
    Abstract: An apparatus for the external fixation and stabilization of a bone fracture comprising fixation pins attached to at least one rigid bar through adjustable clamps which are translatable along said rigid bar wherein the attachment of the pins and bar to the clamps is through articulating balls which allow universal rotational adjustment of each pin or bar. A method for the external fixation and stabilization of a bone fracture utilizing said apparatus is also disclosed.
    Type: Grant
    Filed: September 16, 1985
    Date of Patent: November 4, 1986
    Assignee: Pfizer Hospital Products Group Inc.
    Inventor: Dana C. Mears
  • Patent number: 4619924
    Abstract: Certain 2-alkylthio-2-penem-3-carboxylic acid compounds are useful as antibacterials for treating mammals.
    Type: Grant
    Filed: November 27, 1984
    Date of Patent: October 28, 1986
    Assignee: Pfizer Inc.
    Inventor: Ernest S. Hamanaka
  • Patent number: 4619915
    Abstract: Peptide-substituted heterocyclic compounds having the formula below, pharmaceutically acceptable salts thereof and intermediates therefor; processes for their preparation and use as immunostimulant and antiinfective agents. ##STR1## wherein R is a 5- or 6-membered N-containing heterocyclyl moiety which can have an additional hetero atom selected from N, S or O; R.sup.1 is hydrogen or (C.sub.1-4)alkyl; x is 0 or an integer from 1 to 5; and y is 0 or 1; provided that when y is 0, said N-containing heterocyclyl moiety is linked to the ##STR2## group at its N atom.
    Type: Grant
    Filed: October 19, 1984
    Date of Patent: October 28, 1986
    Assignee: Pfizer Inc.
    Inventor: Jeffrey L. Ives
  • Patent number: 4620019
    Abstract: Chiral sorbinil intermediates of the formula ##STR1## wherein R is hydrogen or benzyloxycarbonyl and Y is hydroxy or amino, processes therefor, and processes for the conversion thereof to sorbinil.
    Type: Grant
    Filed: August 23, 1984
    Date of Patent: October 28, 1986
    Assignee: Pfizer Inc.
    Inventors: Berkeley W. Cue, Jr., Bernard S. Moore
  • Patent number: 4619783
    Abstract: Certain substituted-2-penem-3-carboxylic acid compounds, and pharmaceutically-acceptable salts thereof, can be prepared from the appropriate xanthate or trithiocarbonate by desulfurization, followed by halogenation and ring closure. The corresponding desulfurized and halogenated intermediates are disclosed.
    Type: Grant
    Filed: June 10, 1983
    Date of Patent: October 28, 1986
    Assignee: Pfizer Inc.
    Inventor: Ernest S. Hamanaka
  • Patent number: 4618609
    Abstract: Dihydropyridine derivatives of the formula: ##STR1## and their pharmaceutically acceptable acid addition salts; wherein R is a substituted aryl group;R.sup.1 and R.sup.2 are each independently C.sub.1 -C.sub.3 alkyl;Y is --(CH.sub.2).sub.n -- where n is 2, or --CH.sub.2 CH(CH.sub.3)--; and Het is a 6-membered aromatic heterocyclic group attached to the adjacent oxygen atom by a carbon atom.The compounds have utility as anti-ischaemic and anti-hypertensive agents.
    Type: Grant
    Filed: June 5, 1985
    Date of Patent: October 21, 1986
    Assignee: Pfizer Inc.
    Inventors: David Alker, Simon F. Campbell, Peter E. Cross
  • Patent number: 4618616
    Abstract: 1-substituted-1-haloaryl-1-('-[1H-1,2,4-triazol-1-yl]-cyclopropyl)-2-(1H-1, 2,4-triazol-1-yl)ethane compounds and pharmaceutical compositions thereof are useful in treating fungal infections in mammals and plants.
    Type: Grant
    Filed: May 24, 1985
    Date of Patent: October 21, 1986
    Assignee: Pfizer Inc.
    Inventors: Kenneth Richardson, Robert J. Bass, Kelvin Cooper
  • Patent number: 4617312
    Abstract: A series of 5-(2-alkoxyphenyl)thiazolidinediones and pharmaceutically acceptable salts thereof useful as hypoglycemic agents, aldose reductase inhibitors and as therapeutic agents for the treatment of chronic diabetic complications; intermediates therefore; and process for preparation of said compounds.
    Type: Grant
    Filed: January 17, 1985
    Date of Patent: October 14, 1986
    Assignee: Pfizer Inc.
    Inventor: Rodney C. Schnur
  • Patent number: D286137
    Type: Grant
    Filed: April 5, 1984
    Date of Patent: October 14, 1986
    Assignee: Pfizer Inc.
    Inventors: Charles M. Huck, Edward J. Johnson, Jeremiah A. Lott
  • Patent number: D286181
    Type: Grant
    Filed: August 26, 1983
    Date of Patent: October 14, 1986
    Assignee: Pfizer Hospital Products Group, Inc.
    Inventor: Robert V. Kenna